SignalQuarryGitHub
← Strategy library

Leveraged ETF research · Research strategy

T15 · Technology versus market trend

Uses XLK's strength relative to the broad market to decide whether to hold TECL. The final study did not qualify this rule for selection.

TECL held or settled cash; XLK and other ETFs used only for signalsWeeklyLeveraged TECL fund; portfolio target at most 99%

The idea

How it works

Uses XLK's strength relative to the broad market to decide whether to hold TECL.

Why it might work

Technology leadership versus the market may support leveraged technology exposure.

When it invests

At weekly review, target 99% TECL when XLK is above its 200-day average and its ratio to SPY is trending upward with positive recent relative return.

When it exits

Exit daily below the XLK 100-day average or set cash at weekly review when relative strength fails.

What can go wrong

  • TECL is leveraged and can lose value quickly, including while an exit signal waits for its next execution window.
  • This candidate failed the study's qualification gates despite its simulated return.

Selected research result

T15 base-cost historical backtest

T15 produced a simulated historical return, but failed the finalized study's qualification gates. The result is research evidence, not an approved trading strategy.

Total return1,517.8%Change in simulated portfolio value over the test.
Annualized return33.2%Yearly compounded return; shown only when supported.
Worst drawdown48.3%Largest fall from an earlier portfolio high.
Sharpe ratio0.95Return relative to variability, under the source study's definition.
Trades49Completed simulated trades, when reported.

Read assumptions and limitations →

Research history

Variants and recorded runs

Repeated and diagnostic runs remain accessible under their tested variant. No run is selected by highest return.

Continuous-Base1 result
Historical study

T15 base-cost historical backtest

T15 produced a simulated historical return, but failed the finalized study's qualification gates. The result is research evidence, not an approved trading strategy.

Archived 2026-09-23Total return: 1,517.8%
Read result